The infusion of sodium nitroprusside during surgical operations produced plasma levels of cyanide of up to four times the control value. Plasma thiocyanate showed little change except during prolonged infusion of the drug, but total plasma B12 tended to fall, as did methylcobalamin. Other cobalamins showed little change after nitroprusside infusion for short periods. During longer infusions the ratio of methylcobalamin to adenosyl + hydroxocobalamin fell and cyanocobalamin concentrations were high.
Introduction
The use of sodium nitroprusside as a hypotensive agent was introduced to British anaesthetic practice in 1968 (Jones and Cole, 1968) . Since that tie there have been further reports on its use both during anaesthesia and in the treatment of hypertensive emergencies (Taylor et al., 1970; Mani, 1971; Siegel et al., 1971) . Doubts have been expressed, however, about the safety of sodium nitroprusside since its immediate metabolic produots are most probably cyanide and thiocyanate (Wilson et al., 1971) . In addition to their direct toxic effects it has been suggested tha-t these substances interfere both with J. WILSON, PH.D., F.R.C.P., Consultant Neurologist iodine uptake by the thyroid (Nourok et al., 1964) and with the metabolism of vitamin B12 (Wilson and Matthews, 1966 ). The present study, which was designed to obtain fur;ther information about certain of these effects, was carried out during a recent clinical trial of sodium nitroprusside as a hypotensive agent (to be reported).
Patients and Methods A saline solution of sodium nitroprusside (100 ,ug/ml) was administered by intravenous infusion to induce hypotension during anaesthesia in patients undergoing major orthopaedic surgery. The drip rate was controlled to maintain a systolic arterial pressure of 60 mm Hg in an effort to limit blood loss. A venous blood sample (30 ml) was taken before and immediately after the administration of sodium nitroprusside. The samples were taken into heparinized syringes, with precautions against exposure to white light, and the plasma was separated under red light within one hour. Aliquots were stored at -20'C in foil-wrapped tubes for the estimation of total B12 and plasma cobalamins. Cyanide was isolated without delay from a 5-ml or preferably 10-ml aliquot of the separated plasma by the method of Boxer and Rickards (1950) and estimated by the Aldridge technique (Aldridge, 1945) . Plasma thiocyanate was determined by the latter method using 1 ml of plasma deproteinized wi-th 10% trichloroaceic acid. Erythrocyte cyanide was estimated as described elsewhere (Vesey and Wilson, 1974) . Total B12 was estimated by radioisotopic assay (Matthews et al., 1967) and plasma cobalamins by a chromatobioautographic method (Linnell et (Hill, 1942) , blood, washed erythrocytes, plasma, and urine (Page et al., 1955; Vesey and Wilson, 1974) in vitro. Hydrogen cyanide has also been detected in cases of nitroprusside poiming (Pharmaceutical Yourmal, 1936 , 1948 Lazarus-Barlow and Norman, 1941; Hill, 1942) . Our study, using more senitive techniques for cyanide determnination than hitherto employed, showed ,thait cyanide was liberated in vivo from therapeutic doses, of nitroprusside. The onset of hypotension is very quick and is not thought to be related to the liberation of cyanide (Johnson, 1929; Page et al., 1955) , which occurs slowly in vitro (Vesey and Wilson, 1974) . Nevertheless, the plasma cyanide may reach relatively high levels in paden.ts receiving the drug for only an hour. These levels in a number of cases exceed the levels reported for pa-tients wit;h tropical neuropathy due to chronic exposure to ingested cyanide from cassava (Osuntokun, et al., 1970) . The preliminary study in one patient (case 19) showed that a large amount of the liberated cyanide was in the separated and washed eryfhrocytes. Indeed, it cmbe shown that all the cyanide added to a samle of blood in vitro will pass rapidly into she erythrocytes (Vesey and Wilson, 1974) . This may well affect oxygen transport beoause of the inibLitory action of cyanide on carbonic anhydrase (Horejsi and Komarkova, 1960) in addition to the known effect of cyanide (Schubert and Brill, 1968) , and hence nitroprusside (Sekul et al. 1954 ), on cellular respiration.
Cyanide is converted -to thiocyanate by the enzyme rhodanese (Lang, 1933) . Thiosulphate, which acts as the sulphur donorfor this enzyme, is derived from cysteine by way of f3-mercaptopyruvate. The liver and kidneys contain large amounts of the enzyme rhodanese and it was surprising that during nitroprusside infusion plasma thiocyanate levels rose so slowly. A further enzyme, f31 mercapopyruvate sulphur transferase, is also active in converting cyanide to thiocyanate (Fiedler and Wood, 1956 ). This enzyme occurs in the erythrocytes but in man the red ceLl activity is low and the availability of f3-mercaptopyruvate is probably a further factor (Sorbo, 1957; Kun and Fanshier, 1959) . This fact together with the accumulation of cyanide in ithe erythrocytes may explain the slow rise in plasma thiocyanate. In both animals (Mushett et al., 1952; Friedberg et al., 1965) and man (Lutier et al., 1971) hydroxocobalamin has been shown to be a potent anidote ito cyanide. Probably much of the cyanocobalamin so formed is excreted (Smith, 1968) but evidently a proportion of the cyano radical is incorporated into the 1-C metabolic pool (Boxer and Richards, 1952) . In practice, therefore, it may be wise to give large doses of hydroxocobalmin intravenously before and during the infusion of sodium nitroprusside. The fall in total plasma cobalamins after nitroprusside therapy is noteworthy since it has been shown that there is an inverse relationship between plasma B12 and plasma cyanide levels (Wilson and Matthews, 1966 Osuntokun et al., 1974) . In two p.a,tients (cases 9 and 13; table III) there was an initially high level of plasma cyanocobalamin with raised plasma thiocyanate levels which suggested that they were smokers.
While nitroprusside is a valuable hypotensive agent without obvious toxic effes when used for a limited period cyanide is liberated in vivo and may have adverse biochemical effects, particularly on B12 metabolism. For this reason it ray prove dangerous when given to patients who have low plasma B12 levels, who have impaired liver function, or who suffer from Leber's optic atrophy. We therefore recommend that hydroxocobalamin should be given to patients undergoing nitroprusside therapy. Further work is planned to try -to assess the degree of risk .to the patient to determine the mechanism of niitroprusside breakdown and hypotensive action, and to develope a simple means of monitoring cyanide levels in patients receiving nitroprusside.
